D.Fill Hard Regulatory Status: A Professional Sourcing Guide

D.Fill Hard is a hyaluronic acid dermal filler produced by D.Pharm Co., Ltd., a South Korean manufacturer. It is part of a product line that includes variations like D.Fill Soft and D.Fill Medium, each formulated for specific aesthetic applications. When sourcing any product within this range, professionals prioritize clarity regarding its origin and manufacturer credentials to ensure product integrity and patient safety.

As a product originating from South Korea, D.Fill Hard is expected to comply with specific national regulatory standards. This typically includes approval by the Korean Ministry of Food and Drug Safety (KFDA). KFDA approval indicates that the product has met the safety and efficacy standards required for sale within South Korea.

Manufacturers like D.Pharm Co., Ltd. are also expected to adhere to Good Manufacturing Practices (GMP) and relevant ISO standards (e.g., ISO 13485 for medical devices). These certifications ensure consistent product quality, controlled manufacturing processes, and adherence to international quality management systems. [VERIFY: Specific KFDA approval number for D.Fill Hard; specific GMP and ISO certifications for D.Pharm Co., Ltd.]

Global market access for aesthetic injectables often depends on region-specific regulatory approvals. The CE Mark is vital for products sold within the European Union (EU) and other European Economic Area (EEA) countries, indicating conformity with health, safety, and environmental protection standards. For the United States market, FDA approval is required.

[VERIFY: Whether D.Fill Hard specifically holds a CE Mark for direct EU market entry or FDA approval for the US market.] It is common for Korean manufacturers to focus on KFDA initially, with CE and FDA registrations pursued as part of broader international expansion. The absence of a specific international approval for a given product does not inherently denote lack of quality, but it does influence legal routes for market entry in different regions. Professionals must confirm the product's legal status in their operating territory.

The legal import and distribution of D.Fill Hard varies significantly across major markets:

• European Union (EU) & UK: Access typically requires a valid CE Mark. If a product lacks direct CE certification, its presence in these markets may be via parallel import or through specific national approvals obtained by local distributors, which professionals must verify.
• GCC (Gulf Cooperation Council) & LATAM (Latin America): These regions often have their own national regulatory bodies (e.g., SFDA in Saudi Arabia, ANVISA in Brazil) that require local registration. Products may also enter via distributors with import licenses, contingent on meeting local health authority guidelines.
• APAC (Asia-Pacific): Beyond Korea, countries like Japan, Australia, Singapore, and China each have distinct regulatory frameworks. While some allow products with KFDA or CE marks, many require specific local registrations.

Professionals should always consult local regulations and confirm their supplier's authorization to distribute in their specific market. This applies to the entire Hyaluronic acid dermal filler catalog you might consider sourcing.

Parallel imports, or 'grey market' goods, refer to genuine products legally purchased in one country and imported into another without the consent of the intellectual property owner. While often genuine, these products may lack local regulatory support, proper cold chain management, or product liability coverage in the destination market. Sourcing from unauthorized channels carries risks for clinics, including issues with product authenticity, traceability, and insurance.

To mitigate these risks, clinics should always prioritize suppliers who can provide full transparency regarding their supply chain. This helps ensure the product's integrity, similar to the considerations discussed in How to Verify Genuine Re N Tox 100unit for Your Clinic.

When sourcing D.Fill Hard or any aesthetic injectable, professionals should demand specific documentation from their wholesale distributor. This typically includes:

• Certificate of Authenticity (CoA): Verifies the product is genuine and from the stated manufacturer.
• Batch and Lot Numbers: Essential for traceability and recall procedures.
• Proof of Origin: Documentation confirming the product's manufacturing location.
• Cold Chain Assurance: Evidence that the product has been stored and transported under appropriate temperature conditions.
• Customs Declarations/Import Licenses: Relevant documents proving legal import into your country.

Illustrative wholesale pricing for D.Fill Hard starts at $77.4/unit, with volume tiers offering discounts (e.g., 11 units → 4% off, 51+ units → 8% off). Always verify pricing and available tiers directly with your supplier, similar to reviewing a Neuramis Non-Lidocaine Wholesale Price Guide for Aesthetic P.